Skip to content

Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction

Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01622803
Enrollment
0
Registered
2012-06-19
Start date
2011-08-31
Completion date
2013-08-31
Last updated
2016-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Neoplasm, Obstructive Jaundice

Brief summary

Internal biliary drainage using stent is used for malignant hilar obstruction such as cholangiocarcinoma, hepatocellular carcinoma and other malignancy including metastasis. Bilateral drainage is more physiologic and have more long patency than unilateral drainage. There are two methods of bilateral drainage: Y-stent and side by side. However there are no clinical data about comparing the effectiveness of these two methods. Therefore the investigators want to compare the clinical outcomes of two methods: Y-stent and side by side.

Interventions

PROCEDUREparallel stent

bilateral parallel stent insertion (right and left side)

DEVICEY-stent (BONASTENT M-Hilar)

Bilateral Y-stent insertion (stent in stent type)

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 years * patient who have obstructive jaundice (bilirubin \> 2.0mg/dl) due to hilar malignancy

Exclusion criteria

* patients with endoscopic retrograde cholangiogram is not possible * bleeding tendency (PT INR \> 1.5, platelet \< 50,000) * poor general condition (ECOG 3-4) or cardiopulmonary deterioration * pregnancy

Design outcomes

Primary

MeasureTime frame
The time taken to insert bilateral stentAfter the ERCP procedure

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026